[go: up one dir, main page]

AU2001252191A1 - Uses of bombesin receptor 3 - Google Patents

Uses of bombesin receptor 3

Info

Publication number
AU2001252191A1
AU2001252191A1 AU2001252191A AU5219101A AU2001252191A1 AU 2001252191 A1 AU2001252191 A1 AU 2001252191A1 AU 2001252191 A AU2001252191 A AU 2001252191A AU 5219101 A AU5219101 A AU 5219101A AU 2001252191 A1 AU2001252191 A1 AU 2001252191A1
Authority
AU
Australia
Prior art keywords
bombesin receptor
bombesin
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001252191A
Inventor
Darren Smart
Paul Strijbos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU2001252191A1 publication Critical patent/AU2001252191A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A61K38/105—Bombesin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1787—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AU2001252191A 2000-03-15 2001-03-13 Uses of bombesin receptor 3 Abandoned AU2001252191A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0006289.3A GB0006289D0 (en) 2000-03-15 2000-03-15 New use
GB0006289 2000-03-15
PCT/EP2001/002812 WO2001068120A2 (en) 2000-03-15 2001-03-13 Uses of bombesin receptor 3

Publications (1)

Publication Number Publication Date
AU2001252191A1 true AU2001252191A1 (en) 2001-09-24

Family

ID=9887705

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001252191A Abandoned AU2001252191A1 (en) 2000-03-15 2001-03-13 Uses of bombesin receptor 3

Country Status (6)

Country Link
US (1) US20040023862A1 (en)
EP (1) EP1263455A2 (en)
JP (1) JP2003526674A (en)
AU (1) AU2001252191A1 (en)
GB (1) GB0006289D0 (en)
WO (1) WO2001068120A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10123163A1 (en) 2001-05-09 2003-01-16 Gruenenthal Gmbh Substituted cyclohexane-1,4-diamine derivatives
US7244743B2 (en) 2002-06-05 2007-07-17 Solvay Pharmaceuticals Gmbh Non-peptidic BRS-3 agonists
US20070220272A1 (en) * 2002-06-25 2007-09-20 Campisi Steven E Transaction authentication card
WO2007027225A2 (en) 2005-04-27 2007-03-08 Arena Pharmaceuticals, Inc. Combination therapy for the treatment of obesity and diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
US20080293680A1 (en) * 2005-08-03 2008-11-27 Stefan Peters Substituted Ethane-1,2-Diamines for the Treatment of Alzheimer's Disease II
ES2645995T3 (en) * 2006-05-31 2017-12-11 Abbvie Inc. Compounds such as cannabinoid receptor ligands and their uses
US8841334B2 (en) * 2006-05-31 2014-09-23 Abbvie Inc. Compounds as cannabinoid receptor ligands and uses thereof
WO2008121558A1 (en) 2007-03-28 2008-10-09 Abbott Laboratories 1, 3-thiazol-2 (3h) -ylidene compounds as cannabinoid receptor ligands
US7872033B2 (en) * 2007-04-17 2011-01-18 Abbott Laboratories Compounds as cannabinoid receptor ligands
JP2010527929A (en) * 2007-05-18 2010-08-19 アボット・ラボラトリーズ Novel compounds as cannabinoid receptor ligands
US9193713B2 (en) * 2007-10-12 2015-11-24 Abbvie Inc. Compounds as cannabinoid receptor ligands
US8846730B2 (en) * 2008-09-08 2014-09-30 Abbvie Inc. Compounds as cannabinoid receptor ligands
AR073599A1 (en) * 2008-09-16 2010-11-17 Abbott Lab HETEROCICLICAL COMPOUNDS AS CANABINOID RECEIVERS LIGANDS
PA8854001A1 (en) * 2008-12-16 2010-07-27 Abbott Lab NEW COMPOUNDS AS CANABINOID RECEIVERS LIGANDS
CN119846000B (en) * 2025-03-20 2025-06-24 西安交通大学 Residual alkali determination method applied to composite phase sodium ion battery anode material

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11501205A (en) * 1994-10-17 1999-02-02 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド Human endothelin-bombesin receptor
US6143521A (en) * 1998-07-22 2000-11-07 Smithkline Beecham Corporation Human bombesin receptor subtype-3sb
WO2001010889A1 (en) * 1999-08-04 2001-02-15 Smithkline Beecham Corporation Rat-g-protein coupled receptor brs3

Also Published As

Publication number Publication date
US20040023862A1 (en) 2004-02-05
EP1263455A2 (en) 2002-12-11
GB0006289D0 (en) 2000-05-03
JP2003526674A (en) 2003-09-09
WO2001068120A3 (en) 2002-01-31
WO2001068120A2 (en) 2001-09-20

Similar Documents

Publication Publication Date Title
AU2001227839A1 (en) Shower head
AU2001256320A1 (en) Pigments
AU2002235211A1 (en) Shower head assembly
IL153379A0 (en) 3'-PRODRUGS OF 2'-DEOXY-beta-L-NUCLEOSIDES
AU2001243345A1 (en) 1983, 52881, 2398, 45449, 50289, and 52872, g protein-coupled receptors and uses therefor
AU2001252191A1 (en) Uses of bombesin receptor 3
AU2001269063A1 (en) Shortened synthesis of 3,3-diarylpropylamine derivatives
IL153427A0 (en) 3-azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity
AU2002216079A1 (en) Bombesin receptor antagonists
AU2002218278A1 (en) Water-selective cementing composition
AU2002336437A1 (en) Therapeutic uses of complement receptor 2
AU2002217095A1 (en) Bombesin receptor antagonists
EP1218407A4 (en) Uses of kappa-conotoxin pviia
AU2001223882A1 (en) Receptor
AU7711800A (en) Novel uses of 2-bromopalmitate
AU2001286877A1 (en) 57242, a novel human g protein-coupled receptor family member and uses therefor
AU2001247653A1 (en) 43238, a novel g protein-coupled receptor and uses therefor
AU2001258330A1 (en) New uses of imidazolylmethyl-pyridines
AU2001238707A1 (en) 32705, 23224, 27423, 32700, 32712, novel human g-proteins
AU2001275683A1 (en) Shampoo compositions
AU7434700A (en) Shower head
AU5621501A (en) Regulation of human ephrin-like receptor
AU2002216038A1 (en) Preparation of monofluoroalkenes
HK1051047A (en) 3'-prodrugs of 2'-deoxy-beta-l-nucleosides
AU2001259381A1 (en) Synthesis of diphosphinoarenes